Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: DIASTAT

Summary for Tradename: DIASTAT

Suppliers: see list3
patent expirations by year for

Pharmacology for Tradename: DIASTAT

Drug ClassBenzodiazepine

Clinical Trials for: DIASTAT

Comparison of Absorption of Vaginal Diazepam Using Different Delivery Systems
Status: Recruiting Condition: Metabolism, Drug

A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers
Status: Completed Condition: Epilepsy

Prevention of Posttraumatic Stress Disorder (PTSD) With Diazepam
Status: Active, not recruiting Condition: Posttraumatic Stress Disorder

Exploring the Effects of Diazepam and Lorazepam
Status: Completed Condition: Healthy Subjects

Freedom SOLO Stentless Heart Valve Study
Status: Active, not recruiting Condition: Aortic Stenosis; Aortic Insufficiency

Vaginal Diazepam for the Treatment of Female Pelvic Pain
Status: Recruiting Condition: Pelvic Floor Disorders; Pelvic Pain

A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
Status: Completed Condition: Alcohol Withdrawal

Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
Status: Completed Condition: Seizures

Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse
Status: Recruiting Condition: Alcoholism

Diazepam at the Active Phase of Labor
Status: Not yet recruiting Condition: Pain; Prolonged Labour

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
GEL;RECTAL020648Jul 29, 1997DISCNNo5,462,740<disabled>Y<disabled>
GEL;RECTAL020648Jul 29, 1997RXNo5,462,740<disabled>Y<disabled>
GEL;RECTAL020648Sep 15, 2005RXNo5,462,740<disabled>Y<disabled>
GEL;RECTAL020648Sep 15, 2005RXYes5,462,740<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: DIASTAT

Drugname Dosage Strength RLD Submissiondate
diazepamRectal Gel5 mg/mL, 2mL pre-filled syringeDiastat Acudial12/23/2008
diazepamRectal Gel5 mg/mL, 4mL pre-filled syringeDiastat Acudial12/8/2008
diazepamRectal Gel2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL, 15 mg/3 mL and 20 mg/4 mLDiastat3/23/2004

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology